Evidence map›Paper›PMID 35993783›Full record

ArticleMicrobiology spectrum2022

Flurofamide Prevention and Treatment of

Derek Fleming, Robin Patel

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. [Advances in clinical pharmacotherapy for neonatalZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Derek FlemingDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.ORCID 0000-0002-0054-904X
Robin PatelDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.ORCID 0000-0001-6344-4141
Mayo Clinic · US

Funding

Ureaplasma urealyticum- and Ureaplasma parvum-associated hyperammonemiaR21AI150649 · NIAID · MAYO CLINIC ROCHESTER · PI PATEL, ROBIN · 2020 to 2021
$437k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R21AI150649NIAID NIH HHS R21 AI150649
6 · The paper itself

Abstract

Hyperammonemia (HA) syndrome caused by respiratory infection with ammonia (NH

Indexed as

HyperammonemiaUreaplasma InfectionsAmmoniaAnimalsAnti-Bacterial AgentsBenzamidesMiceUreaUreaplasmaUreaseAmmoniaAnti-Bacterial AgentsBenzamidesflurofamideUreaUreasehyperammonemialung transplantationUreaplasma

Identifiers

PMID35993783
PMCPMC9602998
OpenAlexW4292607913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.